Gayatri Suresh Kumar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of Louisville (2021); University of California, San Francisco (2022); Stanford Medicine (2023–2024); Stanford University (2023–2024)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Gayatri Suresh Kumar's research focuses on developing and evaluating novel therapeutic approaches, particularly in the context of vascular inflammation and atherosclerosis. Recent work includes the development of pro-efferocytic nanotherapies, which have demonstrated a reduction in vascular inflammation without inducing anemia in a large animal model of atherosclerosis. This research has been supported by external funding, though specific grant details are not provided. Kumar has also investigated the design of fibroblast growth factor (FGF1) variants with enhanced cell proliferation activity and improved stability, exploring modifications to the heparin-binding pocket. Additionally, Kumar's publications include case studies on complex medical presentations such as MELAS in a patient with decompensated heart failure and the atypical course of COVID-19 in a cardiac transplant recipient. Scholarship metrics indicate an h-index of 3 across 14 publications with 71 citations.
Metrics
- h-index: 3
- Publications: 16
- Citations: 73
Selected Publications
-
Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1 (2026)
-
26-CCC-15938-ACC WHEN THE THYROID STORMS THE HEART: A CHALLENGING CASE OF THYROTOXICOSIS-INDUCED CARDIOGENIC SHOCK REQUIRING VA-ECMO (2026)
-
Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity (2019)
-
The Abundance of Ergosterol in Candida Species Does not Influence Fluconazole Sensitivity (2014)
-
Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence (2009)
Collaboration Network
Top Collaborators
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Charge reversal in the heparin-binding pocket enhances the stability and activity of the human FGF1
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Campylobacter biofilm phenotype exhibits reduced colonization potential in young chickens and altered in vitro virulence
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
- Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity
Similar Researchers
Based on overlapping research topics